Regulus Therapeutics
RGLS
#8838
Rank
โ‚น9.54 B
Marketcap
โ‚น144.04
Share price
-6.39%
Change (1 day)
-31.53%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น0.66 Billion

According to Regulus Therapeutics's latest financial reports the company's total liabilities are โ‚น0.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น0.66 B-16.24%
2023-12-31โ‚น0.79 B-28.34%
2022-12-31โ‚น1.11 B10.59%
2021-12-31โ‚น1.00 B18.63%
2020-12-31โ‚น0.84 B-46.19%
2019-12-31โ‚น1.57 B-33.38%
2018-12-31โ‚น2.36 B-13.15%
2017-12-31โ‚น2.71 B-10.24%
2016-12-31โ‚น3.02 B168.11%
2015-12-31โ‚น1.13 B-54.82%
2014-12-31โ‚น2.50 B36.74%
2013-12-31โ‚น1.82 B-19.35%
2012-12-31โ‚น2.26 B-49.18%
2011-12-31โ‚น4.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น4.974 T 748,632.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4.887 T 735,425.54%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น968.79 B 145,703.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.399 T 812,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น356.70 B 53,584.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.74 B 914.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.515 T 980,409.46%๐Ÿ‡บ๐Ÿ‡ธ USA